Navigation Links
Conformetrix Appoints Dr Sam Williams as Chief Executive Officer
Date:3/7/2012

MANCHESTER, England, March 7, 2012 /PRNewswire/ --

The Board of Conformetrix Ltd, a leader in optimising drug discovery and design, has appointed Dr Sam Williams as Chief Executive Officer, it is announced today. Dr Williams, who has extensive transactional and business development expertise, was previously a Non-Executive Director of the company. He takes over from one of Conformetrix's founder scientists, Dr Andrew Almond, who becomes Chief Technology Officer.

Conformetrix uses its NMR-based technology to determine the accurate bioactive structures of molecules, an approach which has significant potential in the optimisation of drug discovery and design, as well as the generation of novel drugs. By solving dynamic 3D structures independently of techniques such as X-ray crystallography, the Conformetrix approach derives valuable data more quickly and cheaply than standard approaches. It has been validated by studies both in-house and with partners, and further data and partnering deals are expected this year.

Prior to moving into company management, Dr Williams spent over a decade in the City as a top-rated[1] healthcare analyst, with Robertson Stephens and Lehman Brothers. As well as advising on life sciences investments, he was involved in several IPOs and M&A transactions. Sam has a biology degree from the University of Oxford and a PhD from the University of Cambridge. He will combine his duties at Conformetrix with his role as CEO of Modern Biosciences, a virtual drug development company.

Dr Clive Dix, Chairman of Conformetrix, said, "We welcome Sam as CEO of Conformetrix, where his expertise will be invaluable as the company enters this important next phase of its development. The Board's thanks are also due to Andrew and to Chief Scientific Officer and fellow founder Dr Charles Blundell for their significant contribution to the company's growth so far."

Dr Sam Williams, CEO of Conformetrix, added, "Conformetrix's technology has huge potential in the optimisation of how the pharmaceutical and biotechnology industry generates new pharmaceutical products, and I'm really pleased to be taking on this more active role within the company. The team has expanded significantly during the last year, and I look forward to working with it as Conformetrix matures and moves towards collaborative deals."

[1] Number one-ranked European Biotechnology Analyst in Institutional Investor survey 2004-2006, and in Thomson Extel survey in 2004 and 2005.

Photo available on request

About Conformetrix Ltd

Conformetrix is a Manchester, UK-based company focused on optimising drug discovery and design. It was founded in 2008 as a spin-out from the University of Manchester. The company uses its NMR-based technology to solve the dynamic 3D structures of a broad range of biomolecules, including peptides, cofactors, oligonucleotides and carbohydrates. Since Conformetrix's NMR technology shows what shapes molecules adopt when they are active, it provides high-quality templates for drug discovery and design, and valuable information for drug candidate optimisation. In addition, the data is generated faster and more cheaply than by standard techniques such as X-ray crystallography. Conformetrix has solved biostructures for several large pharmaceutical companies, as well as developing proprietary drug programmes, and has been funded since inception by specialist life science investor Aquarius Equity Partners. For more information, please go to http://www.conformetrix.com.  

For further information please contact:

Conformetrix Ltd
Sam Williams, CEO, +44(0)7881-588-947
Emma Palmer Foster, Strategic Communications Consultant, +44(0)7880-787185
communications@conformetrix.com


'/>"/>
SOURCE Conformetrix Ltd
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Idenix Pharmaceuticals Elects Thomas Hodgson as Chairman of the Board and Appoints Michael Wyzga to Its Board of Directors
2. Codexis Appoints Interim Chief Executive Officer
3. Questcor Pharmaceuticals Appoints Scott M. Whitcup, M.D., to Board of Directors
4. UBM Live Appoints Jim Buckley as Informex Brand Director
5. Samsung Medison America Appoints Michael Podany as Vice President of Sales, West USA
6. Savient Pharmaceuticals Appoints David Y. Norton Interim Chief Executive Officer
7. Savient Pharmaceuticals Appoints Experienced Pharmaceutical Executive, David Veitch as President of Savient Europe
8. Biosyntrx, Inc. Appoints New Board Member & New VP of Operations
9. Octapharma USA Appoints Global Biopharmaceutical Executive David E. Holliday as Vice President of Commercial Development
10. Essentialis Appoints Mahendra G. Shah, Ph.D., to Board of Directors
11. PrimeraDx Appoints David Jackson as VP of Business Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... Breast Cancer Therapeutics in Asia-Pacific Markets to 2021 ... breast cancer market will experience considerable expansion from $1.9 billion ... Annual Growth Rate (CAGR) of 8.5%. --> Breast ... that the Asia-Pacific (APAC) breast cancer ... to $3.4 billion by 2021, at a Compound Annual Growth ...
(Date:2/11/2016)... PLAD, Inc. (OTC Pink: PLAD) is pleased to announce ... company targets, are adding key personnel to their national ... United States Patent and Trademark Office for the characters ... of PLAD, Inc.  In January, PLAD established their presence ... with two new customers, Cumberland Goodwill EMS and Meadville ...
(Date:2/11/2016)... 2016  M3 Biotechnology Inc., spurred by a major "team investment" by Bruce Montgomery , ... an oversubscribed Series A-Round, according to CEO Leen Kawas , PhD. ... ... ... Kawas said the ...
Breaking Medicine Technology:
(Date:2/11/2016)... City, FL (PRWEB) , ... February 11, 2016 ... ... announced the commencement of a master charity program created to assist the people ... 60 days, working closely with nonprofit organizations and community leaders. Their hope is ...
(Date:2/11/2016)... ... February 11, 2016 , ... Duterte Insurance Group, serving ... introduces a new charity campaign to raise funds for Ronald McDonald House Charities. ... https://donate.rmhc.org/ . , Ronald McDonald House (RMH) is an internationally renowned nonprofit ...
(Date:2/11/2016)... ... ... Be Well Medical Group (Be Well) is pleased to announce ... South Columbus St, Suite 201, Alexandria, VA. Be Well Medical Group is a concierge ... of their homes, offices or at the practices’ local office. It is also one ...
(Date:2/11/2016)... ... February 11, 2016 , ... Food Labeling for American ... and wellness best practices in the past couple of decades, and food manufacturers ... Heart Month, which acts as an exceptional opportunity to revise food labels and ...
(Date:2/10/2016)... ... 10, 2016 , ... President Obama’s budget proposal yesterday enables ... medical services via telehealth, estimated to generate more than $160 million in savings ... many years. Although there is more to be done, this represents an ...
Breaking Medicine News(10 mins):